Quality of life following prostate cancer treatments

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Current Urology Reports

• Publication date

  2000-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S11934-000-0038-9PMID 12084344
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quality of life outcomes after brachytherapy for early stage prostate cancer.

  2000cited by this paper
• Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study.

  2000cited by this paper
• European Organization for Research and Treatment of Cancer.

  2000cited by this paper
• Multicenter patient self-reporting questionnaire on impotence, incontinence and stricture after radical prostatectomy.

  2000influential reference
• Prostate cancer treated by anti-androgens: is sexual function preserved?

  2000cited by this paper
• Changes in health-related quality of life in the first year after treatment for prostate cancer: results from CaPSURE.

  1999cited by this paper
• Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

  1999cited by this paper
• Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer.

  1999cited by this paper
• Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors.

  1999cited by this paper
• Changes in quality of life following treatment for early prostate cancer.

  1999cited by this paper
• Recovery of health related quality of life in the year after radical prostatectomy: early experience.

  1999cited by this paper
• Self-assessed health-related quality of life in men being treated for prostate cancer with radiotherapy: instrument validation and its relation to patient-assessed bother of symptoms.

  1999cited by this paper
• Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone.

  1999cited by this paper
• Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer.

  1999cited by this paper
• Quality of Life Issues Relating to Endocrine Treatment Options

  1999cited by this paper
• Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer.

  1999cited by this paper
• Late side effects unchanged 4–8 years after radiotherapy for prostate carcinoma

  1999cited by this paper
• Sexual function and bother after radical prostatectomy or radiation for prostate cancer: multivariate quality-of-life analysis from CaPSURE. Cancer of the Prostate Strategic Urologic Research Endeavor.

  1999cited by this paper
• Long-term results of a randomized trial for the treatment of Stages B2 and C prostate cancer: radical prostatectomy versus external beam radiation therapy with a common endocrine therapy in both modalities.

  1999cited by this paper
• Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study.

  1998cited by this paper
• Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years.

  1998cited by this paper
• Quality of life in advanced prostate cancer: results of a randomized therapeutic trial.

  1998cited by this paper
• Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer

  1998cited by this paper
• The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure.

  1998cited by this paper
• Differences in urologist and patient assessments of health related quality of life in men with prostate cancer: results of the CaPSURE database.

  1998cited by this paper
• Health-related quality of life and sequelae in patients treated with brachytherapy and external beam irradiation for localized prostate cancer.

  1998cited by this paper
• Quality-of-life outcomes in long-term survivors of advanced prostate cancer.

  1998cited by this paper
• Late effects of radiation therapy for prostate carcinoma: the patient's perspective of bladder, bowel and sexual morbidity.

  1998cited by this paper
• Baseline quality of life of patients with advanced prostate cancer. European Organization for Research and Treatment of Cancer (EORTC), Genito-Urinary Tract Cancer Cooperative Group (GUT-CCG)

  1997cited by this paper
• Health-related quality of life among patients with metastatic prostate cancer.

  1997cited by this paper
• Assessment of endpoints for clinical trials for localized prostate cancer.

  1997cited by this paper
• Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument.

  1997cited by this paper
• Patient self-assessment of complications and quality of life after conformal neutron and photon irradiation for localized prostate cancer.

  1997cited by this paper
• Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.

  1997cited by this paper
• Quality of life and treatment outcomes

  1997cited by this paper
• Quality of life after permanent prostate implant.

  1997cited by this paper
• Dimensions of quality of life expressed by men treated for metastatic prostate cancer.

  1997cited by this paper
• Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group.

  1997cited by this paper
• Quality of life in patients with prostatic cancer: results from a Swedish population study.

  1997cited by this paper
• Outcomes of external-beam radiation therapy for prostate cancer: a study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas.

  1996cited by this paper
• Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: the patient's perspective.

  1996cited by this paper
• Current results and patient selection for nerve-sparing radical retropubic prostatectomy.

  1995cited by this paper
• Decreased sexual capacity after external radiation therapy for prostate cancer impairs quality of life.

  1995cited by this paper
• Quality-of-life outcomes in men treated for localized prostate cancer.

  1995influential reference
• Current results and patient selection for nerve-sparing radical retropubic prostatectomy.

  1995cited by this paper
• Quality of life: radical prostatectomy versus radiation therapy for prostate cancer.

  1995cited by this paper
• Effect of radical prostatectomy for prostate cancer on patient quality of life: results from a Medicare survey.

  1995cited by this paper
• Quality of life of incontinent men after radical prostatectomy.

  1994cited by this paper
• National patterns of prostate cancer treatment by radical prostatectomy: results of a survey by the American College of Surgeons Commission on Cancer.

  1994cited by this paper
• Self‐assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age‐matched control population

  1994cited by this paper
• The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

  1993cited by this paper
• Assessing health-related quality of life for clinical decision-making

  1993cited by this paper
• A comparison of the quality of life of patients with metastatic prostate cancer who received or did not receive hormonal therapy

  1993cited by this paper

• Increase in Testosterone Levels and Improvement of Clinical Symptoms in Eugonadic men With a Prolactin-secreting Adenoma

  2024cites this paper
• The role of estradiol in male reproductive function

  2016cites this paper
• Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

  2014cites this paper
• Role of estrogen in normal male function: clinical implications for patients with prostate cancer on androgen deprivation therapy.

  2011cites this paper
• Das lokal begrenzte Prostatakarzinom

  2010cites this paper
• Reliability of assessment of urgency and other symptoms indicating anal sphincter, large bowel or urinary dysfunction

  2006cites this paper
• Towards elimination of anal-sphincter and rectal dysfunction after radiation therapy for prostate cancer

  2004cites this paper
• Urinary symptom flare following I-125 prostate brachytherapy.

  2003cites this paper
• Urinary continence and quality of life in the first year after radical perineal prostatectomy.

  2003cites this paper